TCM
SNY icon

Triumph Capital Management’s Sanofi SNY Stock Holding History

Triumph Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39K Sell
103
-3
-3% -$134 ﹤0.01% 1391
2026
Q1 		$5.11K Buy
106
+12
+13% +$560 ﹤0.01% 1298
2025
Q4 		$4.55K Buy
+94
New +$4.66K ﹤0.01% 1294

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Triumph Capital Management's SNY Position: Q2 2026 in Review

Triumph Capital Management reduced its Sanofi (SNY) stake by 2.8% in Q2 2026, selling an estimated $134 and leaving 103 shares worth $4.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Triumph Capital Management first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.11K in Q1 2026. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Triumph Capital Management held 103 shares of Sanofi worth $4.39K as of Q2 2026.
  • Triumph Capital Management sold 3 Sanofi shares in Q2 2026, an estimated $134.
  • Sanofi made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1391 holding.
  • Triumph Capital Management first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
  • Triumph Capital Management's Sanofi position peaked at $5.11K in Q1 2026.
  • 717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.